Strategic Intelligence.
Automated.
Our platform connects billions of biomedical entities to automate the strategic deliverables that drive drug development — competitive landscapes, target product profiles, conference intelligence, and more.
Every deliverable is AI-generated and validated by our in-house life science experts — with white-glove service when you need it.
For Strategy Teams
Automated strategic deliverables for competitive intelligence, portfolio planning, and commercial strategy.
Competitive Intelligence
Automated competitive landscape assessments that cover the full pipeline — from early discovery through approval. Structured around key players, assets, market positioning, and strategic differentiation. Ready for board-level presentation.
- Full pipeline mapping: early discovery → IND → approval
- Competitor matrix with asset profiles and market positioning
- Curated and AI-validated from direct sources
- Near-term catalysts, patents, outcomes, and regulatory intelligence
KOL Map
Identify and map key opinion leaders across therapeutic areas. Our platform finds and relates academics, principal investigators, and industry leaders at all levels — connecting them to deals, funding, exits, discoveries, diseases, drugs, and technologies.
- KOL identification and ranking
- Company and institutional directories
- Publication, patent, and trial mapping
- Influence networks and visualization
Trials Map
Our Trials Map extrapolates outcome, endpoint, and safety data from global clinical trials for competitive risk assessments, enabling pipeline, biomarker, and cross-therapy mapping:
- Outcome measurements
- Recruitment rates
- Adverse events
- Treatment analysis
For Research Teams
AI-powered tools for biomedical exploration, drug discovery, and scientific analysis.
Knowledge Map
Like an AI-enabled research assistant, Knowledge Maps gather documents and data according to explicit criteria, enabling the user to find connections across the biomedical universe. The Knowledge Map is the core of our platform and satisfies many use cases, including:
- Basic research
- Translational research
- Literature review
- Hypotheses generation
Drug Discovery
Our Drug Map connects drugs and chemicals to targets and indications through the lens of bioavailability, trials, SARs and PG effects. We provide detailed data on interactions that make it a highly efficient tool for in silico analysis, including:
- Target identification
- Drug repurposing
- PK/PD modelling
- Drug safety & efficacy
Omics Analysis
This tool can identify pathways that are enriched by and overlap with one or more genes, and provides analysis and statistics across multiple databases, and is species-specific. The added ability to connect gene variants (SNVs, Indels, Deletions, CNAs) with known cancer biomarkers, allows for:
- Gene enrichment analysis
- Pathway identification
- Variant analysis
- Clinical interpretation
PhenoMap
Extracting data from thousands of documents is an arduous task. Our platform easily extracts high-frequency themes across documents to reveal common associations among genes, pathways, drugs and diseases.
- Shortcut for biomarker discovery
- Output and visualization
- Pre-select publication cohorts
- Multi-criteria